
By Pharma Doc:
Background:
Gilead's (NASDAQ:GILD) Sofosbuvir (Sovaldi) was approved by the FDA in late 2013 and has shattered the record for the best drug l...
By Pharma Doc:
Background:
Gilead's (NASDAQ:GILD) Sofosbuvir (Sovaldi) was approved by the FDA in late 2013 and has shattered the record for the best drug l...